Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 8.62797574 |
2 | negative regulation of cell killing (GO:0031342) | 8.11838457 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.11838457 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.43934236 |
5 | ensheathment of neurons (GO:0007272) | 7.01173024 |
6 | axon ensheathment (GO:0008366) | 7.01173024 |
7 | myelination (GO:0042552) | 7.00709026 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.94310593 |
9 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.52264650 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.51320463 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.51035953 |
12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.47116057 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.27804629 |
14 | leukocyte aggregation (GO:0070486) | 5.94769836 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.89846263 |
16 | activated T cell proliferation (GO:0050798) | 5.69457718 |
17 | cellular response to interleukin-15 (GO:0071350) | 5.27943580 |
18 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.24459157 |
19 | cholesterol biosynthetic process (GO:0006695) | 5.20627385 |
20 | response to interleukin-15 (GO:0070672) | 5.15630976 |
21 | myelin maintenance (GO:0043217) | 5.13111458 |
22 | macrophage activation involved in immune response (GO:0002281) | 5.00424253 |
23 | neutrophil activation involved in immune response (GO:0002283) | 4.99232347 |
24 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95074990 |
25 | modulation by symbiont of host defense response (GO:0052031) | 4.95074990 |
26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95074990 |
27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95074990 |
28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95074990 |
29 | modulation by symbiont of host immune response (GO:0052553) | 4.95074990 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.84297404 |
31 | amyloid precursor protein metabolic process (GO:0042982) | 4.84042057 |
32 | negative regulation of neurotransmitter transport (GO:0051589) | 4.83725313 |
33 | detection of bacterium (GO:0016045) | 4.80774315 |
34 | detection of other organism (GO:0098543) | 4.79522741 |
35 | sterol biosynthetic process (GO:0016126) | 4.58733991 |
36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.50729124 |
37 | creatine metabolic process (GO:0006600) | 4.50467245 |
38 | L-amino acid import (GO:0043092) | 4.46590386 |
39 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.46249227 |
40 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.46249227 |
41 | negative thymic T cell selection (GO:0045060) | 4.39808851 |
42 | negative T cell selection (GO:0043383) | 4.38573113 |
43 | response to methylmercury (GO:0051597) | 4.37467007 |
44 | establishment of mitochondrion localization (GO:0051654) | 4.37309403 |
45 | regulation of collateral sprouting (GO:0048670) | 4.32842419 |
46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.30368389 |
47 | glycerophospholipid catabolic process (GO:0046475) | 4.29662805 |
48 | oligodendrocyte differentiation (GO:0048709) | 4.25949355 |
49 | regulation of gamma-delta T cell activation (GO:0046643) | 4.25762914 |
50 | positive thymic T cell selection (GO:0045059) | 4.25730053 |
51 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.18121960 |
52 | negative regulation of phagocytosis (GO:0050765) | 4.14414632 |
53 | negative regulation of protein localization to cell surface (GO:2000009) | 4.14202544 |
54 | neutrophil activation (GO:0042119) | 4.13180898 |
55 | T cell migration (GO:0072678) | 4.12925341 |
56 | microglial cell activation (GO:0001774) | 4.08300250 |
57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.07848721 |
58 | import into cell (GO:0098657) | 4.02243098 |
59 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.00731316 |
60 | cellular extravasation (GO:0045123) | 3.97985401 |
61 | apical protein localization (GO:0045176) | 3.92704786 |
62 | isoprenoid biosynthetic process (GO:0008299) | 3.92078314 |
63 | asymmetric protein localization (GO:0008105) | 3.90385560 |
64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.85136669 |
65 | astrocyte development (GO:0014002) | 3.82711075 |
66 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.81529185 |
67 | positive T cell selection (GO:0043368) | 3.81467512 |
68 | thymic T cell selection (GO:0045061) | 3.80730124 |
69 | substantia nigra development (GO:0021762) | 3.80170382 |
70 | regulation of T cell tolerance induction (GO:0002664) | 3.75841644 |
71 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.75598020 |
72 | T cell selection (GO:0045058) | 3.74124812 |
73 | eye photoreceptor cell differentiation (GO:0001754) | 3.72050520 |
74 | photoreceptor cell differentiation (GO:0046530) | 3.72050520 |
75 | granulocyte activation (GO:0036230) | 3.70690137 |
76 | presynaptic membrane organization (GO:0097090) | 3.69915635 |
77 | amyloid precursor protein catabolic process (GO:0042987) | 3.68730743 |
78 | detection of external biotic stimulus (GO:0098581) | 3.68716764 |
79 | myeloid cell activation involved in immune response (GO:0002275) | 3.67236721 |
80 | very long-chain fatty acid metabolic process (GO:0000038) | 3.62592508 |
81 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.60271341 |
82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.58605960 |
83 | response to lipoprotein particle (GO:0055094) | 3.58459693 |
84 | regulation of B cell differentiation (GO:0045577) | 3.57562612 |
85 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.57170687 |
86 | negative regulation of interleukin-12 production (GO:0032695) | 3.57106800 |
87 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.55793709 |
88 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.55454260 |
89 | membrane tubulation (GO:0097320) | 3.51515717 |
90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48980107 |
91 | B cell receptor signaling pathway (GO:0050853) | 3.48785129 |
92 | interferon-gamma production (GO:0032609) | 3.48598101 |
93 | response to redox state (GO:0051775) | 3.48060135 |
94 | myelination in peripheral nervous system (GO:0022011) | 3.45510335 |
95 | peripheral nervous system axon ensheathment (GO:0032292) | 3.45510335 |
96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45176903 |
97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.44173841 |
98 | response to type I interferon (GO:0034340) | 3.39700350 |
99 | respiratory burst (GO:0045730) | 3.38909720 |
100 | regulation of tolerance induction (GO:0002643) | 3.38354621 |
101 | presynaptic membrane assembly (GO:0097105) | 3.38294867 |
102 | regulation of lipoprotein metabolic process (GO:0050746) | 3.37631830 |
103 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.37485199 |
104 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.36957374 |
105 | cellular response to type I interferon (GO:0071357) | 3.35370064 |
106 | type I interferon signaling pathway (GO:0060337) | 3.35370064 |
107 | adhesion of symbiont to host cell (GO:0044650) | 3.33742882 |
108 | virion attachment to host cell (GO:0019062) | 3.33742882 |
109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.31973740 |
110 | L-phenylalanine catabolic process (GO:0006559) | 3.31973740 |
111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31117655 |
112 | macrophage activation (GO:0042116) | 3.30010402 |
113 | protein palmitoylation (GO:0018345) | 3.27825939 |
114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26439029 |
115 | regulation of mast cell degranulation (GO:0043304) | 3.26418412 |
116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.26349450 |
117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25414118 |
118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23973273 |
119 | detection of biotic stimulus (GO:0009595) | 3.21906714 |
120 | immunoglobulin mediated immune response (GO:0016064) | 3.20179672 |
121 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.20178091 |
122 | acyl-CoA biosynthetic process (GO:0071616) | 3.19820080 |
123 | thioester biosynthetic process (GO:0035384) | 3.19820080 |
124 | positive regulation of mast cell activation (GO:0033005) | 3.19057463 |
125 | adult walking behavior (GO:0007628) | 3.18507398 |
126 | negative regulation of type 2 immune response (GO:0002829) | 3.14674900 |
127 | amino acid import (GO:0043090) | 3.14424021 |
128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14169924 |
129 | response to host immune response (GO:0052572) | 3.14169924 |
130 | regulation of cell killing (GO:0031341) | 3.10185698 |
131 | negative regulation of innate immune response (GO:0045824) | 3.08957213 |
132 | regulation of regulatory T cell differentiation (GO:0045589) | 3.08905165 |
133 | magnesium ion transport (GO:0015693) | 3.08718678 |
134 | leukocyte degranulation (GO:0043299) | 3.06662119 |
135 | leukocyte cell-cell adhesion (GO:0007159) | 3.05310190 |
136 | response to peptidoglycan (GO:0032494) | 3.04817219 |
137 | cellular defense response (GO:0006968) | 3.04169975 |
138 | positive regulation of isotype switching (GO:0045830) | 3.03858647 |
139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03779189 |
140 | positive regulation of B cell differentiation (GO:0045579) | 3.03692943 |
141 | positive regulation of cell killing (GO:0031343) | 3.01721947 |
142 | lymphocyte migration (GO:0072676) | 3.00584790 |
143 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99672342 |
144 | neuronal action potential propagation (GO:0019227) | 2.98839826 |
145 | negative regulation of axonogenesis (GO:0050771) | 2.98587061 |
146 | GPI anchor biosynthetic process (GO:0006506) | 2.98511804 |
147 | T cell receptor signaling pathway (GO:0050852) | 2.97851021 |
148 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96872659 |
149 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.96865690 |
150 | axon development (GO:0061564) | 2.96144254 |
151 | GPI anchor metabolic process (GO:0006505) | 2.95936978 |
152 | nerve growth factor signaling pathway (GO:0038180) | 2.94824370 |
153 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91889068 |
154 | response to host (GO:0075136) | 2.91889068 |
155 | response to host defenses (GO:0052200) | 2.91889068 |
156 | myeloid leukocyte mediated immunity (GO:0002444) | 2.91521593 |
157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90636882 |
158 | signal complex assembly (GO:0007172) | 2.89739729 |
159 | glycosylceramide metabolic process (GO:0006677) | 2.88794209 |
160 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88288316 |
161 | positive regulation of Rap GTPase activity (GO:0032854) | 2.87309014 |
162 | regulation of leukocyte degranulation (GO:0043300) | 2.86787047 |
163 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86264857 |
164 | nucleotide transmembrane transport (GO:1901679) | 2.86089227 |
165 | transmission of nerve impulse (GO:0019226) | 2.83856380 |
166 | positive regulation of action potential (GO:0045760) | 2.81014095 |
167 | limb bud formation (GO:0060174) | 2.78966450 |
168 | neurotransmitter uptake (GO:0001504) | 2.78691302 |
169 | protein localization to endosome (GO:0036010) | 2.77776509 |
170 | neuron remodeling (GO:0016322) | 2.76593331 |
171 | peptidyl-cysteine modification (GO:0018198) | 2.73843365 |
172 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.71708089 |
173 | L-phenylalanine metabolic process (GO:0006558) | 2.71708089 |
174 | heme transport (GO:0015886) | 2.70398167 |
175 | Golgi to endosome transport (GO:0006895) | 2.66659145 |
176 | response to lead ion (GO:0010288) | 2.66552156 |
177 | peripheral nervous system development (GO:0007422) | 2.65719590 |
178 | positive regulation of glial cell differentiation (GO:0045687) | 2.64556189 |
179 | iron coordination entity transport (GO:1901678) | 2.63113158 |
180 | cerebellar granule cell differentiation (GO:0021707) | 2.61295807 |
181 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60991871 |
182 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.58210214 |
183 | protein neddylation (GO:0045116) | 2.58175723 |
184 | glial cell development (GO:0021782) | 2.54151330 |
185 | negative regulation of acute inflammatory response (GO:0002674) | 2.52501794 |
186 | glutathione biosynthetic process (GO:0006750) | 2.52259356 |
187 | cholesterol metabolic process (GO:0008203) | 2.49747289 |
188 | negative regulation of JUN kinase activity (GO:0043508) | 2.49476543 |
189 | organ growth (GO:0035265) | 2.49303780 |
190 | regulation of interleukin-13 production (GO:0032656) | 2.48674112 |
191 | cellular response to epinephrine stimulus (GO:0071872) | 2.48552315 |
192 | neuronal ion channel clustering (GO:0045161) | 2.45389072 |
193 | neural nucleus development (GO:0048857) | 2.44931995 |
194 | ear development (GO:0043583) | 2.44578517 |
195 | negative regulation of axon extension (GO:0030517) | 2.41740778 |
196 | adhesion of symbiont to host (GO:0044406) | 2.41064445 |
197 | positive regulation of gliogenesis (GO:0014015) | 2.41010788 |
198 | central nervous system myelination (GO:0022010) | 11.7326522 |
199 | axon ensheathment in central nervous system (GO:0032291) | 11.7326522 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.59917406 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54955436 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.91280597 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61147898 |
5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.29465640 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.15438173 |
7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.11159415 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06279230 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04178909 |
10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94748483 |
11 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.71044597 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68728986 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65120025 |
14 | MYB_26560356_Chip-Seq_TH2_Human | 2.60852546 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60725826 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.58756698 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57721820 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55087256 |
19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.53423925 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.50768196 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.44239751 |
22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38972347 |
23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.35018855 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31487458 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.28350146 |
26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.27200652 |
27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.25799686 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25101391 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23830956 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22365524 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21630272 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17070854 |
33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15422743 |
34 | MYB_26560356_Chip-Seq_TH1_Human | 2.14013049 |
35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.11208257 |
36 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09360767 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09186733 |
38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.05329533 |
39 | MAF_26560356_Chip-Seq_TH2_Human | 2.03742243 |
40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03613397 |
41 | MYC_22102868_ChIP-Seq_BL_Human | 2.01880556 |
42 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00715593 |
43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00335459 |
44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93577919 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93092379 |
46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92267007 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91469175 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90841503 |
49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87940453 |
50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82821878 |
51 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82817826 |
52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81451864 |
53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80318136 |
54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80318136 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80092303 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79977367 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79894173 |
58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79560434 |
59 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79242670 |
60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78420305 |
61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.77197673 |
62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76908477 |
63 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72778106 |
64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72772384 |
65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72241157 |
66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69452914 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69446366 |
68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.69430132 |
69 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67219912 |
70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67025299 |
71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66118787 |
72 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65289775 |
73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62257190 |
74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57038231 |
75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55148345 |
76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54671627 |
77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54096383 |
78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51644659 |
79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51232529 |
80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48881826 |
81 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46796974 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46042056 |
83 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.44695101 |
84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44301805 |
85 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.43994919 |
86 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40889870 |
87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39884757 |
88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37824243 |
89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36965765 |
90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36529024 |
91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35750601 |
92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35399683 |
93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33401205 |
94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33325051 |
95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33090910 |
96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33068243 |
97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32063760 |
98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31395633 |
99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30315102 |
100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29624971 |
101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29272350 |
102 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28597341 |
103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28160870 |
104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27978230 |
105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27452732 |
106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27245677 |
107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26553963 |
108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26052249 |
109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26052249 |
110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23185467 |
111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23173783 |
112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22231173 |
113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19863384 |
114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19261961 |
115 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.18695285 |
116 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16848935 |
117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16762112 |
118 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14836495 |
119 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14610897 |
120 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14161351 |
121 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13558107 |
122 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13348410 |
123 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13109548 |
124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12897001 |
125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12841977 |
126 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11761055 |
127 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11359949 |
128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10536421 |
129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10200523 |
130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09993816 |
131 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09914799 |
132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09884546 |
133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09602683 |
134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09513089 |
135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08783344 |
136 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08505305 |
137 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07909055 |
138 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06753109 |
139 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05376167 |
140 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05291478 |
141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04966768 |
142 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02101366 |
143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01943661 |
144 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01706630 |
145 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01597451 |
146 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01562732 |
147 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00893856 |
148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00259424 |
149 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99157055 |
150 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98916566 |
151 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98798076 |
152 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98788025 |
153 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98290960 |
154 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97796360 |
155 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97526582 |
156 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97507521 |
157 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97161554 |
158 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.96938441 |
159 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96724640 |
160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95798347 |
161 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95798347 |
162 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95644129 |
163 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94953553 |
164 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94860126 |
165 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94790433 |
166 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94666747 |
167 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94647668 |
168 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94157040 |
169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93435217 |
170 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93070563 |
171 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92908553 |
172 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92498995 |
173 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92479600 |
174 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92007073 |
175 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91610403 |
176 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91208970 |
177 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90869420 |
178 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90831313 |
179 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89654814 |
180 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89652653 |
181 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89163098 |
182 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88762636 |
183 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88599432 |
184 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88245508 |
185 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87965423 |
186 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86796974 |
187 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86612322 |
188 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86604431 |
189 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86351542 |
190 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.86130434 |
191 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85933399 |
192 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85928072 |
193 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85888725 |
194 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84679009 |
195 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84389371 |
196 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83700996 |
197 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82773692 |
198 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82416276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000920_abnormal_myelination | 5.78582338 |
2 | MP0003724_increased_susceptibility_to | 4.25462960 |
3 | MP0005671_abnormal_response_to | 4.22139705 |
4 | MP0003950_abnormal_plasma_membrane | 3.94378220 |
5 | MP0003436_decreased_susceptibility_to | 3.92310534 |
6 | MP0003880_abnormal_central_pattern | 3.73013029 |
7 | MP0001835_abnormal_antigen_presentation | 3.60584940 |
8 | MP0003763_abnormal_thymus_physiology | 3.43157258 |
9 | MP0001800_abnormal_humoral_immune | 3.27015490 |
10 | MP0003329_amyloid_beta_deposits | 3.05843891 |
11 | MP0005000_abnormal_immune_tolerance | 3.04552662 |
12 | MP0004270_analgesia | 3.04277557 |
13 | MP0005025_abnormal_response_to | 3.03565733 |
14 | MP0002419_abnormal_innate_immunity | 2.94917761 |
15 | * MP0003690_abnormal_glial_cell | 2.81985592 |
16 | MP0002723_abnormal_immune_serum | 2.81141912 |
17 | MP0002420_abnormal_adaptive_immunity | 2.73811339 |
18 | MP0005387_immune_system_phenotype | 2.73148402 |
19 | MP0001790_abnormal_immune_system | 2.73148402 |
20 | MP0001819_abnormal_immune_cell | 2.69714764 |
21 | MP0003303_peritoneal_inflammation | 2.66914129 |
22 | MP0004885_abnormal_endolymph | 2.63794109 |
23 | MP0009785_altered_susceptibility_to | 2.62977832 |
24 | MP0001529_abnormal_vocalization | 2.62303986 |
25 | MP0000685_abnormal_immune_system | 2.60351573 |
26 | MP0003300_gastrointestinal_ulcer | 2.58923341 |
27 | MP0002452_abnormal_antigen_presenting | 2.58882973 |
28 | MP0003136_yellow_coat_color | 2.51561401 |
29 | MP0004742_abnormal_vestibular_system | 2.49536894 |
30 | MP0001905_abnormal_dopamine_level | 2.45924964 |
31 | MP0003634_abnormal_glial_cell | 2.42247931 |
32 | MP0002272_abnormal_nervous_system | 2.38240080 |
33 | MP0002132_abnormal_respiratory_system | 2.37074650 |
34 | MP0001486_abnormal_startle_reflex | 2.34013347 |
35 | MP0004142_abnormal_muscle_tone | 2.33869189 |
36 | MP0004381_abnormal_hair_follicle | 2.27934372 |
37 | MP0005451_abnormal_body_composition | 2.25560204 |
38 | MP0009333_abnormal_splenocyte_physiolog | 2.25417757 |
39 | MP0002405_respiratory_system_inflammati | 2.21669046 |
40 | MP0005171_absent_coat_pigmentation | 2.20234463 |
41 | MP0001485_abnormal_pinna_reflex | 2.15329778 |
42 | MP0002064_seizures | 2.12300840 |
43 | * MP0002398_abnormal_bone_marrow | 2.07316409 |
44 | MP0005409_darkened_coat_color | 2.05874693 |
45 | MP0003195_calcinosis | 2.04603311 |
46 | * MP0000716_abnormal_immune_system | 2.03258346 |
47 | MP0003632_abnormal_nervous_system | 1.98690791 |
48 | MP0010678_abnormal_skin_adnexa | 1.98630707 |
49 | MP0000778_abnormal_nervous_system | 1.98075610 |
50 | MP0004947_skin_inflammation | 1.97632297 |
51 | MP0001533_abnormal_skeleton_physiology | 1.89067737 |
52 | MP0000383_abnormal_hair_follicle | 1.86160712 |
53 | MP0002229_neurodegeneration | 1.86157505 |
54 | MP0005464_abnormal_platelet_physiology | 1.84638589 |
55 | MP0010155_abnormal_intestine_physiology | 1.81144431 |
56 | MP0000703_abnormal_thymus_morphology | 1.80712197 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.80427623 |
58 | MP0005410_abnormal_fertilization | 1.79057895 |
59 | MP0002148_abnormal_hypersensitivity_rea | 1.75648089 |
60 | MP0000858_altered_metastatic_potential | 1.74987066 |
61 | MP0000462_abnormal_digestive_system | 1.74864078 |
62 | MP0003866_abnormal_defecation | 1.73852524 |
63 | MP0004859_abnormal_synaptic_plasticity | 1.73344359 |
64 | MP0002722_abnormal_immune_system | 1.72242924 |
65 | MP0005423_abnormal_somatic_nervous | 1.71208651 |
66 | MP0009046_muscle_twitch | 1.69248034 |
67 | MP0000604_amyloidosis | 1.68442150 |
68 | MP0000689_abnormal_spleen_morphology | 1.68047896 |
69 | MP0001845_abnormal_inflammatory_respons | 1.65248762 |
70 | MP0004043_abnormal_pH_regulation | 1.57120091 |
71 | MP0009745_abnormal_behavioral_response | 1.56013336 |
72 | * MP0002429_abnormal_blood_cell | 1.55278804 |
73 | MP0008260_abnormal_autophagy | 1.54326177 |
74 | MP0003635_abnormal_synaptic_transmissio | 1.51593213 |
75 | MP0003631_nervous_system_phenotype | 1.49527340 |
76 | MP0003191_abnormal_cellular_cholesterol | 1.48224170 |
77 | MP0004883_abnormal_blood_vessel | 1.46194093 |
78 | MP0001873_stomach_inflammation | 1.43683219 |
79 | MP0002734_abnormal_mechanical_nocicepti | 1.38163382 |
80 | MP0008469_abnormal_protein_level | 1.36157144 |
81 | MP0005551_abnormal_eye_electrophysiolog | 1.34634996 |
82 | MP0000647_abnormal_sebaceous_gland | 1.32815388 |
83 | MP0000955_abnormal_spinal_cord | 1.30583804 |
84 | MP0003183_abnormal_peptide_metabolism | 1.30529529 |
85 | MP0003172_abnormal_lysosome_physiology | 1.29742894 |
86 | MP0000566_synostosis | 1.28273795 |
87 | MP0003633_abnormal_nervous_system | 1.27338659 |
88 | MP0008569_lethality_at_weaning | 1.27155888 |
89 | MP0002933_joint_inflammation | 1.26679854 |
90 | MP0002882_abnormal_neuron_morphology | 1.26378701 |
91 | MP0004147_increased_porphyrin_level | 1.26083128 |
92 | MP0004134_abnormal_chest_morphology | 1.21605776 |
93 | MP0002822_catalepsy | 1.21186311 |
94 | MP0002572_abnormal_emotion/affect_behav | 1.20228103 |
95 | MP0001440_abnormal_grooming_behavior | 1.18687102 |
96 | MP0002066_abnormal_motor_capabilities/c | 1.17298256 |
97 | MP0002998_abnormal_bone_remodeling | 1.16235619 |
98 | MP0000465_gastrointestinal_hemorrhage | 1.15418861 |
99 | MP0001346_abnormal_lacrimal_gland | 1.14799902 |
100 | MP0001661_extended_life_span | 1.13753112 |
101 | MP0003448_altered_tumor_morphology | 1.13739176 |
102 | MP0002396_abnormal_hematopoietic_system | 1.13638923 |
103 | MP0002277_abnormal_respiratory_mucosa | 1.12352195 |
104 | MP0003938_abnormal_ear_development | 1.10716469 |
105 | MP0002063_abnormal_learning/memory/cond | 1.09036544 |
106 | MP0003075_altered_response_to | 1.08976542 |
107 | MP0001299_abnormal_eye_distance/ | 1.08787921 |
108 | MP0005386_behavior/neurological_phenoty | 1.08786676 |
109 | MP0004924_abnormal_behavior | 1.08786676 |
110 | MP0001851_eye_inflammation | 1.08384474 |
111 | MP0005166_decreased_susceptibility_to | 1.07948365 |
112 | MP0001963_abnormal_hearing_physiology | 1.07362683 |
113 | MP0000747_muscle_weakness | 1.07148213 |
114 | MP0005075_abnormal_melanosome_morpholog | 1.06066672 |
115 | MP0002752_abnormal_somatic_nervous | 1.05907486 |
116 | MP0009840_abnormal_foam_cell | 1.04051508 |
117 | MP0002067_abnormal_sensory_capabilities | 1.03670632 |
118 | MP0003828_pulmonary_edema | 1.02427273 |
119 | MP0005623_abnormal_meninges_morphology | 1.01969155 |
120 | MP0009278_abnormal_bone_marrow | 0.98946018 |
121 | MP0001970_abnormal_pain_threshold | 0.98584087 |
122 | MP0005164_abnormal_response_to | 0.98449003 |
123 | MP0000579_abnormal_nail_morphology | 0.98394306 |
124 | MP0000467_abnormal_esophagus_morphology | 0.97062890 |
125 | MP0005058_abnormal_lysosome_morphology | 0.96897188 |
126 | MP0006082_CNS_inflammation | 0.96426989 |
127 | MP0005195_abnormal_posterior_eye | 0.95333461 |
128 | MP0001177_atelectasis | 0.94366402 |
129 | MP0000490_abnormal_crypts_of | 0.92847508 |
130 | MP0005310_abnormal_salivary_gland | 0.91775803 |
131 | MP0001545_abnormal_hematopoietic_system | 0.91207257 |
132 | MP0005397_hematopoietic_system_phenotyp | 0.91207257 |
133 | MP0005408_hypopigmentation | 0.88284073 |
134 | MP0001986_abnormal_taste_sensitivity | 0.88071175 |
135 | MP0003045_fibrosis | 0.87415289 |
136 | MP0009764_decreased_sensitivity_to | 0.86644505 |
137 | MP0004130_abnormal_muscle_cell | 0.86133007 |
138 | MP0002166_altered_tumor_susceptibility | 0.85729178 |
139 | MP0003937_abnormal_limbs/digits/tail_de | 0.82682865 |
140 | MP0000762_abnormal_tongue_morphology | 0.80985136 |
141 | MP0002796_impaired_skin_barrier | 0.80181786 |
142 | MP0002295_abnormal_pulmonary_circulatio | 0.78429975 |
143 | MP0003656_abnormal_erythrocyte_physiolo | 0.78396774 |
144 | MP0004510_myositis | 0.76894511 |
145 | MP0002733_abnormal_thermal_nociception | 0.74386046 |
146 | MP0001663_abnormal_digestive_system | 0.72882390 |
147 | MP0009763_increased_sensitivity_to | 0.72794056 |
148 | MP0000026_abnormal_inner_ear | 0.72203434 |
149 | MP0002152_abnormal_brain_morphology | 0.72131991 |
150 | MP0004185_abnormal_adipocyte_glucose | 0.70715976 |
151 | MP0008873_increased_physiological_sensi | 0.70566674 |
152 | MP0002090_abnormal_vision | 0.69413083 |
153 | MP0002118_abnormal_lipid_homeostasis | 0.68207068 |
154 | MP0004145_abnormal_muscle_electrophysio | 0.66928004 |
155 | MP0003878_abnormal_ear_physiology | 0.66515073 |
156 | MP0005377_hearing/vestibular/ear_phenot | 0.66515073 |
157 | MP0005253_abnormal_eye_physiology | 0.63651334 |
158 | MP0005390_skeleton_phenotype | 0.62614631 |
159 | MP0005332_abnormal_amino_acid | 0.61592936 |
160 | MP0001348_abnormal_lacrimal_gland | 0.61442774 |
161 | MP0004036_abnormal_muscle_relaxation | 0.60553519 |
162 | MP0002133_abnormal_respiratory_system | 0.59848114 |
163 | MP0005388_respiratory_system_phenotype | 0.59848114 |
164 | MP0001340_abnormal_eyelid_morphology | 0.59332993 |
165 | MP0002006_tumorigenesis | 0.58858869 |
166 | MP0001727_abnormal_embryo_implantation | 0.58229253 |
167 | MP0008875_abnormal_xenobiotic_pharmacok | 0.57959350 |
168 | MP0008874_decreased_physiological_sensi | 0.57040710 |
169 | MP0003453_abnormal_keratinocyte_physiol | 0.56110827 |
170 | MP0003638_abnormal_response/metabolism_ | 0.55841138 |
171 | MP0003795_abnormal_bone_structure | 0.55621940 |
172 | MP0001968_abnormal_touch/_nociception | 0.54574828 |
173 | MP0006072_abnormal_retinal_apoptosis | 0.53781424 |
174 | MP0004264_abnormal_extraembryonic_tissu | 0.53624568 |
175 | MP0002019_abnormal_tumor_incidence | 0.53418010 |
176 | MP0004858_abnormal_nervous_system | 0.52799233 |
177 | MP0009765_abnormal_xenobiotic_induced | 0.52104677 |
178 | MP0001765_abnormal_ion_homeostasis | 0.50357669 |
179 | MP0000249_abnormal_blood_vessel | 0.48028872 |
180 | MP0003566_abnormal_cell_adhesion | 0.47039175 |
181 | MP0004484_altered_response_of | 0.45581507 |
182 | MP0005381_digestive/alimentary_phenotyp | 0.45290079 |
183 | MP0000470_abnormal_stomach_morphology | 0.44618510 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.84372182 |
2 | Neurofibrillary tangles (HP:0002185) | 6.60030542 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.49055682 |
4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.49055682 |
5 | Recurrent abscess formation (HP:0002722) | 6.29384132 |
6 | Recurrent bacterial skin infections (HP:0005406) | 5.66280212 |
7 | Myositis (HP:0100614) | 5.61220007 |
8 | Parakeratosis (HP:0001036) | 5.51115362 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.40000709 |
10 | Abnormality of macrophages (HP:0004311) | 5.21577050 |
11 | Sensory axonal neuropathy (HP:0003390) | 5.03989302 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.94687892 |
13 | Abnormality of the corticospinal tract (HP:0002492) | 4.85507065 |
14 | Orchitis (HP:0100796) | 4.76009790 |
15 | Cerebral inclusion bodies (HP:0100314) | 4.72390045 |
16 | Stomatitis (HP:0010280) | 4.50633945 |
17 | T lymphocytopenia (HP:0005403) | 4.48821785 |
18 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.46791395 |
19 | Retrobulbar optic neuritis (HP:0100654) | 4.42823870 |
20 | Optic neuritis (HP:0100653) | 4.42823870 |
21 | Abnormality of T cell number (HP:0011839) | 4.33777227 |
22 | Peripheral hypomyelination (HP:0007182) | 4.30904339 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.04610869 |
24 | Gastrointestinal infarctions (HP:0005244) | 3.99605493 |
25 | Increased IgE level (HP:0003212) | 3.98891090 |
26 | Cerebral hypomyelination (HP:0006808) | 3.96448852 |
27 | Encephalitis (HP:0002383) | 3.91972825 |
28 | Recurrent fungal infections (HP:0002841) | 3.87757338 |
29 | Onion bulb formation (HP:0003383) | 3.86955196 |
30 | Meningitis (HP:0001287) | 3.82985548 |
31 | Gingivitis (HP:0000230) | 3.76988790 |
32 | Recurrent skin infections (HP:0001581) | 3.63125147 |
33 | Spastic gait (HP:0002064) | 3.57962021 |
34 | Supranuclear gaze palsy (HP:0000605) | 3.57571074 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53753985 |
36 | Obstructive lung disease (HP:0006536) | 3.53753985 |
37 | Mediastinal lymphadenopathy (HP:0100721) | 3.45136586 |
38 | Leukocytosis (HP:0001974) | 3.44430582 |
39 | Hemiplegia (HP:0002301) | 3.43520901 |
40 | Intention tremor (HP:0002080) | 3.42787889 |
41 | Pustule (HP:0200039) | 3.40532392 |
42 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.38562390 |
43 | Vasculitis (HP:0002633) | 3.31722293 |
44 | Abnormality of T cells (HP:0002843) | 3.30724809 |
45 | Nasal polyposis (HP:0100582) | 3.29806028 |
46 | Insidious onset (HP:0003587) | 3.29253947 |
47 | Termporal pattern (HP:0011008) | 3.29253947 |
48 | Hypochromic anemia (HP:0001931) | 3.27800832 |
49 | Keratoconjunctivitis sicca (HP:0001097) | 3.26119321 |
50 | Urticaria (HP:0001025) | 3.23605817 |
51 | Spontaneous hematomas (HP:0007420) | 3.21838110 |
52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.17817927 |
53 | Increased IgM level (HP:0003496) | 3.11454893 |
54 | Abnormality of glycolysis (HP:0004366) | 3.11385511 |
55 | Increased serum pyruvate (HP:0003542) | 3.11385511 |
56 | Dysmetria (HP:0001310) | 3.11364331 |
57 | Panhypogammaglobulinemia (HP:0003139) | 3.07326116 |
58 | Abnormal auditory evoked potentials (HP:0006958) | 3.06706214 |
59 | Hypochromic microcytic anemia (HP:0004840) | 3.04205967 |
60 | Leukodystrophy (HP:0002415) | 3.00475738 |
61 | Chest pain (HP:0100749) | 3.00230927 |
62 | Keratoconjunctivitis (HP:0001096) | 2.99914130 |
63 | Prolonged bleeding time (HP:0003010) | 2.97258554 |
64 | Granulocytopenia (HP:0001913) | 2.96560375 |
65 | Scanning speech (HP:0002168) | 2.96016087 |
66 | Slow saccadic eye movements (HP:0000514) | 2.95597153 |
67 | Cellulitis (HP:0100658) | 2.92916706 |
68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89073502 |
69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89073502 |
70 | Alacrima (HP:0000522) | 2.85235839 |
71 | Retinal dysplasia (HP:0007973) | 2.84958297 |
72 | Papilledema (HP:0001085) | 2.77980251 |
73 | Anteriorly placed anus (HP:0001545) | 2.77779548 |
74 | Spastic paraparesis (HP:0002313) | 2.76704610 |
75 | Recurrent viral infections (HP:0004429) | 2.76527159 |
76 | Inflammation of the large intestine (HP:0002037) | 2.76206830 |
77 | Eosinophilia (HP:0001880) | 2.75643976 |
78 | Episodic fever (HP:0001954) | 2.74121784 |
79 | Gastrointestinal inflammation (HP:0004386) | 2.70833043 |
80 | Cerebral hemorrhage (HP:0001342) | 2.67624962 |
81 | Lymphopenia (HP:0001888) | 2.65895854 |
82 | Pulmonary infiltrates (HP:0002113) | 2.64261075 |
83 | Gingival bleeding (HP:0000225) | 2.61930739 |
84 | Premature skin wrinkling (HP:0100678) | 2.60706570 |
85 | Clumsiness (HP:0002312) | 2.59411822 |
86 | Ankle clonus (HP:0011448) | 2.57759606 |
87 | Hypophosphatemic rickets (HP:0004912) | 2.57728191 |
88 | Abnormality of the nasal mucosa (HP:0000433) | 2.57208696 |
89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.55730272 |
90 | Stridor (HP:0010307) | 2.55495939 |
91 | Myokymia (HP:0002411) | 2.54567816 |
92 | Pulmonary embolism (HP:0002204) | 2.53773674 |
93 | Thickened helices (HP:0000391) | 2.52606778 |
94 | CNS hypomyelination (HP:0003429) | 2.52173726 |
95 | Hypergammaglobulinemia (HP:0010702) | 2.52163348 |
96 | Abnormality of eosinophils (HP:0001879) | 2.50478670 |
97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.44655083 |
98 | Akinesia (HP:0002304) | 2.44585519 |
99 | Absent septum pellucidum (HP:0001331) | 2.43972145 |
100 | Anorexia (HP:0002039) | 2.42223997 |
101 | Increased circulating renin level (HP:0000848) | 2.39827665 |
102 | Autoamputation (HP:0001218) | 2.39752680 |
103 | Abnormality of T cell physiology (HP:0011840) | 2.37268046 |
104 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.36519439 |
105 | Epistaxis (HP:0000421) | 2.35411178 |
106 | Hemoptysis (HP:0002105) | 2.35408030 |
107 | Split foot (HP:0001839) | 2.32319349 |
108 | Chronic otitis media (HP:0000389) | 2.31494213 |
109 | Hypoplastic pelvis (HP:0008839) | 2.31097502 |
110 | Abnormality of binocular vision (HP:0011514) | 2.29275757 |
111 | Diplopia (HP:0000651) | 2.29275757 |
112 | IgM deficiency (HP:0002850) | 2.27050141 |
113 | Spastic tetraparesis (HP:0001285) | 2.26854775 |
114 | Erythroderma (HP:0001019) | 2.24542146 |
115 | Periodontitis (HP:0000704) | 2.23434805 |
116 | Coronal craniosynostosis (HP:0004440) | 2.21922353 |
117 | Decreased lacrimation (HP:0000633) | 2.20107580 |
118 | Sepsis (HP:0100806) | 2.19664416 |
119 | Arterial thrombosis (HP:0004420) | 2.19580185 |
120 | Severe combined immunodeficiency (HP:0004430) | 2.18049469 |
121 | Morphological abnormality of the inner ear (HP:0011390) | 2.17418085 |
122 | Pheochromocytoma (HP:0002666) | 2.16915296 |
123 | Microcytic anemia (HP:0001935) | 2.15315964 |
124 | Recurrent bronchitis (HP:0002837) | 2.15104148 |
125 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13717243 |
126 | Papilloma (HP:0012740) | 2.11015430 |
127 | Verrucae (HP:0200043) | 2.11015430 |
128 | Increased CSF protein (HP:0002922) | 2.10629111 |
129 | Skin ulcer (HP:0200042) | 2.09445163 |
130 | Axonal loss (HP:0003447) | 2.09442011 |
131 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.09309694 |
132 | Colitis (HP:0002583) | 2.09048931 |
133 | Peritonitis (HP:0002586) | 2.08956387 |
134 | Gangrene (HP:0100758) | 2.07579057 |
135 | Methylmalonic acidemia (HP:0002912) | 2.07087462 |
136 | Hepatosplenomegaly (HP:0001433) | 2.07041671 |
137 | Abnormality of the septum pellucidum (HP:0007375) | 2.06823355 |
138 | Hyperlipoproteinemia (HP:0010980) | 2.06819700 |
139 | Metabolic alkalosis (HP:0200114) | 2.05955909 |
140 | Amyloidosis (HP:0011034) | 2.05861519 |
141 | Cupped ear (HP:0000378) | 2.05544022 |
142 | Joint swelling (HP:0001386) | 2.05448572 |
143 | Paraparesis (HP:0002385) | 2.05104751 |
144 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04981448 |
145 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04981448 |
146 | Aplasia involving bones of the extremities (HP:0009825) | 2.04981448 |
147 | Lower limb muscle weakness (HP:0007340) | 2.04393274 |
148 | Petechiae (HP:0000967) | 2.03301854 |
149 | Esophageal atresia (HP:0002032) | 2.02750010 |
150 | Acute hepatic failure (HP:0006554) | 2.01865727 |
151 | Purpura (HP:0000979) | 2.01541604 |
152 | Poor speech (HP:0002465) | 2.01308882 |
153 | Hypoproteinemia (HP:0003075) | 2.01011083 |
154 | Agammaglobulinemia (HP:0004432) | 1.99730677 |
155 | Megalencephaly (HP:0001355) | 1.98956916 |
156 | Hypomagnesemia (HP:0002917) | 1.98921535 |
157 | Global brain atrophy (HP:0002283) | 1.98174984 |
158 | Increased serum ferritin (HP:0003281) | 1.96811770 |
159 | Renal Fanconi syndrome (HP:0001994) | 1.96289797 |
160 | Hypokalemic alkalosis (HP:0001949) | 1.95558655 |
161 | Autoimmune hemolytic anemia (HP:0001890) | 1.94652921 |
162 | Prolonged neonatal jaundice (HP:0006579) | 1.93906688 |
163 | Osteomyelitis (HP:0002754) | 1.93173529 |
164 | Synostosis involving the elbow (HP:0003938) | 1.93069470 |
165 | Humeroradial synostosis (HP:0003041) | 1.93069470 |
166 | Neuroendocrine neoplasm (HP:0100634) | 1.92856917 |
167 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91168435 |
168 | Intrahepatic cholestasis (HP:0001406) | 1.90533405 |
169 | Anomalous pulmonary venous return (HP:0010772) | 1.90445455 |
170 | Premature loss of primary teeth (HP:0006323) | 1.90425638 |
171 | Hypoplasia of the iris (HP:0007676) | 1.90292282 |
172 | Tetraplegia (HP:0002445) | 1.89093496 |
173 | Gastrointestinal stroma tumor (HP:0100723) | 1.86713997 |
174 | Foot dorsiflexor weakness (HP:0009027) | 1.85733909 |
175 | Patchy hypopigmentation of hair (HP:0011365) | 1.85386469 |
176 | White forelock (HP:0002211) | 1.85046760 |
177 | Hyporeflexia of lower limbs (HP:0002600) | 1.84126296 |
178 | Infantile muscular hypotonia (HP:0008947) | 1.83856175 |
179 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83127184 |
180 | Disinhibition (HP:0000734) | 1.82699602 |
181 | Acne (HP:0001061) | 1.82103750 |
182 | Partial duplication of thumb phalanx (HP:0009944) | 1.81197364 |
183 | Abnormality of iron homeostasis (HP:0011031) | 1.81018748 |
184 | Choreoathetosis (HP:0001266) | 1.80449187 |
185 | Stenosis of the external auditory canal (HP:0000402) | 1.80328934 |
186 | Muscle fiber splitting (HP:0003555) | 1.79672719 |
187 | Abnormality of the pleura (HP:0002103) | 1.79163375 |
188 | Adrenal hypoplasia (HP:0000835) | 1.79022859 |
189 | Urinary incontinence (HP:0000020) | 1.78506103 |
190 | Decreased motor nerve conduction velocity (HP:0003431) | 1.78435159 |
191 | Vertigo (HP:0002321) | 1.78397183 |
192 | Clonus (HP:0002169) | 1.74943850 |
193 | Gowers sign (HP:0003391) | 1.73426880 |
194 | Barrel-shaped chest (HP:0001552) | 1.72209473 |
195 | Bowel incontinence (HP:0002607) | 1.72109158 |
196 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.71876670 |
197 | Hammertoe (HP:0001765) | 1.71854115 |
198 | Peripheral demyelination (HP:0011096) | 1.69798211 |
199 | Partial agenesis of the corpus callosum (HP:0001338) | 1.69103558 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 6.72414072 |
2 | MAP4K1 | 4.81414118 |
3 | OXSR1 | 4.60271223 |
4 | RIPK4 | 4.34200969 |
5 | EPHB1 | 3.75249884 |
6 | WNK4 | 2.73270757 |
7 | BCR | 2.72483075 |
8 | PKN1 | 2.72289146 |
9 | CDK19 | 2.59730778 |
10 | TXK | 2.59219206 |
11 | GRK6 | 2.59206324 |
12 | ZAP70 | 2.56669975 |
13 | PBK | 2.46777975 |
14 | TYK2 | 2.45089775 |
15 | ERN1 | 2.41079824 |
16 | TNK2 | 2.40581805 |
17 | MAPKAPK5 | 2.35608895 |
18 | MET | 2.33157519 |
19 | BLK | 2.28161810 |
20 | FGFR2 | 2.25105845 |
21 | MAP2K3 | 2.21550828 |
22 | TNIK | 2.15481339 |
23 | IRAK4 | 2.13571732 |
24 | WNK1 | 2.05106649 |
25 | BTK | 2.00820127 |
26 | LIMK1 | 1.93734617 |
27 | UHMK1 | 1.81105478 |
28 | CSNK1G3 | 1.80317271 |
29 | JAK1 | 1.73672374 |
30 | CSNK1A1L | 1.72849764 |
31 | NEK6 | 1.70644490 |
32 | MAP3K3 | 1.65321445 |
33 | ICK | 1.64872193 |
34 | JAK3 | 1.62504744 |
35 | SYK | 1.62140827 |
36 | HCK | 1.62081063 |
37 | CLK1 | 1.60781785 |
38 | PNCK | 1.60567301 |
39 | CAMK2B | 1.60088636 |
40 | TESK2 | 1.58816277 |
41 | NTRK1 | 1.53790411 |
42 | TAOK3 | 1.53159056 |
43 | PRPF4B | 1.51912002 |
44 | LCK | 1.51086744 |
45 | ROCK2 | 1.50549008 |
46 | CSNK1G1 | 1.41070165 |
47 | MAP3K11 | 1.38553857 |
48 | CSNK1G2 | 1.37872955 |
49 | FGR | 1.36684295 |
50 | STK10 | 1.35566500 |
51 | MST4 | 1.32443273 |
52 | PAK6 | 1.30894849 |
53 | SIK3 | 1.30182951 |
54 | TAOK1 | 1.29831221 |
55 | CAMK2D | 1.29155738 |
56 | SGK223 | 1.23418774 |
57 | SGK494 | 1.23418774 |
58 | EPHA4 | 1.20634667 |
59 | IKBKE | 1.18261121 |
60 | LYN | 1.16178735 |
61 | MAP3K1 | 1.15330586 |
62 | JAK2 | 1.12656577 |
63 | CASK | 1.11387257 |
64 | CAMK2G | 1.07705324 |
65 | PAK3 | 1.00892665 |
66 | PTK2B | 1.00848772 |
67 | TYRO3 | 0.99243693 |
68 | PRKCQ | 0.96271645 |
69 | TBK1 | 0.95514116 |
70 | STK38 | 0.94445649 |
71 | MARK3 | 0.92609792 |
72 | DYRK2 | 0.92015218 |
73 | CSF1R | 0.87760244 |
74 | TEC | 0.86934280 |
75 | MARK2 | 0.85457680 |
76 | PTK6 | 0.83714212 |
77 | PRKD1 | 0.82065297 |
78 | BMPR2 | 0.81621023 |
79 | CAMK2A | 0.80310097 |
80 | MAP3K14 | 0.79856676 |
81 | SIK2 | 0.79627048 |
82 | MAP3K7 | 0.79583731 |
83 | CDK14 | 0.79351958 |
84 | MARK1 | 0.78886414 |
85 | TRIB3 | 0.78137989 |
86 | TGFBR2 | 0.77794810 |
87 | LRRK2 | 0.74653427 |
88 | ARAF | 0.74254738 |
89 | CDK5 | 0.74138314 |
90 | PDPK1 | 0.72919451 |
91 | MUSK | 0.70848653 |
92 | CDK15 | 0.70767107 |
93 | CAMKK1 | 0.69447070 |
94 | PIM1 | 0.68781207 |
95 | MAPK12 | 0.68770374 |
96 | YES1 | 0.66032260 |
97 | CDK18 | 0.64745476 |
98 | CDK11A | 0.64441448 |
99 | FGFR3 | 0.64018607 |
100 | PRKCE | 0.61160913 |
101 | SGK3 | 0.60848496 |
102 | MAPK15 | 0.57841239 |
103 | ERBB4 | 0.57444575 |
104 | IRAK2 | 0.55710283 |
105 | FYN | 0.54811707 |
106 | PIK3CA | 0.53884360 |
107 | RPS6KA5 | 0.53069440 |
108 | IKBKB | 0.52653538 |
109 | GRK5 | 0.52061056 |
110 | ITK | 0.51829728 |
111 | MAP3K6 | 0.51318164 |
112 | FGFR4 | 0.50878341 |
113 | RET | 0.49755222 |
114 | CSNK1D | 0.49188796 |
115 | CDK4 | 0.48235170 |
116 | GSK3A | 0.48211632 |
117 | HIPK2 | 0.47906474 |
118 | BMPR1B | 0.47841028 |
119 | KIT | 0.47769534 |
120 | SGK2 | 0.47630890 |
121 | STK11 | 0.47535634 |
122 | SMG1 | 0.46661566 |
123 | KDR | 0.46657312 |
124 | DMPK | 0.45339028 |
125 | PRKG1 | 0.44377512 |
126 | NTRK2 | 0.43906328 |
127 | PHKG2 | 0.43894009 |
128 | PHKG1 | 0.43894009 |
129 | CAMKK2 | 0.43347130 |
130 | TRPM7 | 0.43191279 |
131 | KSR2 | 0.41081629 |
132 | MAP3K2 | 0.40958884 |
133 | CDC42BPA | 0.40181291 |
134 | CSNK1A1 | 0.39782182 |
135 | MAP2K6 | 0.39242491 |
136 | SIK1 | 0.38138092 |
137 | CAMK1G | 0.37371987 |
138 | PRKACB | 0.37091020 |
139 | MAPK13 | 0.36063524 |
140 | GRK7 | 0.35803359 |
141 | PRKCH | 0.35237440 |
142 | FES | 0.34757276 |
143 | MAP2K4 | 0.34577033 |
144 | PAK1 | 0.34488646 |
145 | TESK1 | 0.34432508 |
146 | PDK1 | 0.34207825 |
147 | PRKCZ | 0.33287447 |
148 | RAF1 | 0.32985516 |
149 | TAOK2 | 0.32158868 |
150 | MAP2K2 | 0.32134027 |
151 | MAPKAPK2 | 0.31190887 |
152 | DYRK1B | 0.31185839 |
153 | NLK | 0.30952594 |
154 | PRKG2 | 0.30001307 |
155 | MAPK7 | 0.29922788 |
156 | ADRBK2 | 0.29221344 |
157 | RPS6KC1 | 0.28293153 |
158 | PRKD2 | 0.27065781 |
159 | PRKACA | 0.26719714 |
160 | INSR | 0.26302654 |
161 | DYRK1A | 0.25529847 |
162 | MAPK10 | 0.25132748 |
163 | PDGFRB | 0.24438061 |
164 | MKNK1 | 0.24167927 |
165 | MAP3K13 | 0.24115483 |
166 | BMX | 0.23776599 |
167 | IRAK1 | 0.23632520 |
168 | DAPK3 | 0.23289044 |
169 | OBSCN | 0.22651883 |
170 | ROCK1 | 0.22171485 |
171 | GRK1 | 0.21486507 |
172 | CSK | 0.21440333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.51028474 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.88196876 |
3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.67206401 |
4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.70028475 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.60872322 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.43281434 |
7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.99988481 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.95629334 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82814457 |
10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.64958158 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55737425 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 2.53003088 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52340453 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.26384846 |
15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.20317643 |
16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.18806145 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14010562 |
18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.03214942 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99676631 |
20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97607354 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96030028 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93825469 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74798751 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.73398804 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.72494688 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72385436 |
27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.70187936 |
28 | Measles_Homo sapiens_hsa05162 | 1.67816570 |
29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67557545 |
30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.66059462 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65525812 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63568244 |
33 | Axon guidance_Homo sapiens_hsa04360 | 1.63281103 |
34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62874367 |
35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49937107 |
36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49144263 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47568647 |
38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44845959 |
39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40747134 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40410867 |
41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40066884 |
42 | Protein export_Homo sapiens_hsa03060 | 1.39533577 |
43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37067470 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.33523559 |
45 | Legionellosis_Homo sapiens_hsa05134 | 1.28069463 |
46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23201203 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23138087 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17402299 |
49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17379510 |
50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16719538 |
51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14716752 |
52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13254036 |
53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12581274 |
54 | Platelet activation_Homo sapiens_hsa04611 | 1.12267781 |
55 | Parkinsons disease_Homo sapiens_hsa05012 | 1.12121263 |
56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10944894 |
57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10147884 |
58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09087894 |
59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07209965 |
60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05949402 |
61 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05356964 |
62 | Influenza A_Homo sapiens_hsa05164 | 1.04922254 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03719308 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99702092 |
65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97907376 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95896787 |
67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94667397 |
68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91633607 |
69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91622454 |
70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89414541 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89365405 |
72 | Pertussis_Homo sapiens_hsa05133 | 0.88968179 |
73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88389847 |
74 | Peroxisome_Homo sapiens_hsa04146 | 0.88126227 |
75 | Long-term depression_Homo sapiens_hsa04730 | 0.86633721 |
76 | Apoptosis_Homo sapiens_hsa04210 | 0.85588803 |
77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85311901 |
78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85035571 |
79 | Hepatitis B_Homo sapiens_hsa05161 | 0.82705356 |
80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82456072 |
81 | Tight junction_Homo sapiens_hsa04530 | 0.82101884 |
82 | Hepatitis C_Homo sapiens_hsa05160 | 0.81837092 |
83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81562546 |
84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81391589 |
85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79166006 |
86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79127010 |
87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79110518 |
88 | Shigellosis_Homo sapiens_hsa05131 | 0.76414590 |
89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76232420 |
90 | Morphine addiction_Homo sapiens_hsa05032 | 0.76093561 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73258256 |
92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72439445 |
93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72196269 |
94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71060715 |
95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68508776 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.67087739 |
97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67065343 |
98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66883881 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65556891 |
100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64963690 |
101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64508696 |
102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64422336 |
103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64096250 |
104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62599616 |
105 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62366144 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62330264 |
107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61743993 |
108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61510762 |
109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61094426 |
110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60966290 |
111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60949868 |
112 | Salmonella infection_Homo sapiens_hsa05132 | 0.60565391 |
113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60478313 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59682977 |
115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59598142 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57160962 |
117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56486542 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56401897 |
119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55968597 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55824354 |
121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55107893 |
122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55036751 |
123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55018403 |
124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54912693 |
125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53879430 |
126 | Lysosome_Homo sapiens_hsa04142 | 0.53698933 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53525556 |
128 | Amoebiasis_Homo sapiens_hsa05146 | 0.53230167 |
129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52903388 |
130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51221539 |
131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50799201 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50203656 |
133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50150380 |
134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49331679 |
135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47936576 |
136 | Asthma_Homo sapiens_hsa05310 | 0.47576310 |
137 | Glioma_Homo sapiens_hsa05214 | 0.46183528 |
138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45803467 |
139 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45518973 |
140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45331883 |
141 | Salivary secretion_Homo sapiens_hsa04970 | 0.45138985 |
142 | Mineral absorption_Homo sapiens_hsa04978 | 0.43826693 |
143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43711630 |
144 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43597381 |
145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43291600 |
146 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42740163 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41357023 |
148 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41192100 |
149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41001715 |
150 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40512391 |
151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40149497 |
152 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39667815 |
153 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39520834 |
154 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39283850 |
155 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39173289 |
156 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39169276 |
157 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.39050101 |
158 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38694082 |
159 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37386990 |
160 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36824927 |
161 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36093351 |
162 | Phototransduction_Homo sapiens_hsa04744 | 0.35968116 |
163 | Malaria_Homo sapiens_hsa05144 | 0.35353736 |
164 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34277905 |
165 | Phagosome_Homo sapiens_hsa04145 | 0.34176187 |
166 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33964095 |
167 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33788672 |
168 | ABC transporters_Homo sapiens_hsa02010 | 0.32564183 |
169 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32343492 |
170 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32133122 |
171 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31220819 |
172 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.29288657 |
173 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27259350 |
174 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27229373 |
175 | Prion diseases_Homo sapiens_hsa05020 | 0.25657418 |
176 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23427544 |
177 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23068232 |